On this page you'll find media statements issued by MSWA containing information about events, fundraising, investment in research, services and facilities and corporate news. Media outlets are welcome to follow up with us for further information.

Tony Millar - Chief Experience Officer
M 0456 415 832
E [email protected]

25 February 2025

The Exopulse Mollii Suit is a cutting-edge treatment for managing pain and increasing mobility for people with neurological conditions. MSWA is working to ensure Western Australians are among the first to be able to access the game-changing treatment. Read more >

3 March 2025

In MS Australia's latest $5.7 million research grant round, 35 new research initiatives will be funded focusing on advancing better treatments, prevention, and cures for MS. Thanks to the investment and support of MSWA, funded by the generosity of Western Australians, this will be MS Australia's largest ever research grant round. Read more.

25 March 2025

Kylie Jones became the first-ever MSWA Client to win the Mega Home Lottery, bagging the $3.3 million Grand Prize Package, with her husband Brett. While the stunning City Beach home hit every point when it came to luxury, its standard layout didn’t cater for someone living with MS and posed significant challenges for Mrs Jones’ mobility. Mr Jones said that the lottery win gave them the freedom to create something truly life changing for Mrs Jones. Read more.

8 May 2024
MSWA announces the commencement of construction of the long-awaited Montario Quarter. This initiative underscores MSWA's unwavering commitment to providing top-tier support for individuals neurological conditions and spinal cord injuries across Western Australia. Read more >

29 November 2023
A world-leading clinical trial will seek to reverse neurological damage caused by primary progressive multiple sclerosis (PPMS) in Australians living with the debilitating condition, in an announcement made today at the MS Australia Progress in Research Conference in Perth. Read more >

5 July 2023
New clues found in hunt for MS cure. MSWA's Chief Marketing Officer to interview Dr. Fabis-Pedrini on the revolutionary MS research breakthrough. Read more >

2 December 2022
MSWA's 2022-2023 commitment to neurological research. Read more >

21 September 2021
New MSWA CEO appointed. Read more >

20 July 2021
MSWA Commitment to Research, 2021 Announcement. Read more >

13 May 2021
CEO Marcus Stafford Announces Retirement. Read more >

8 March 2021
MSWA is WA’s leading contributor to neurological research. Read more >

2 March 2021
MSWA and ECU research funding partnership: New motion-sensing technology set to make waves for people living with neurological conditions. Read more >

Media releases